Mortality and Related Risk Factors After Hip Arthroplasty

Femoral Head Necrosis Clinical Trial

Official title:

Mortality and Related Risk Factors After Hip Arthroplasty, a Retrospective Study

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05548257
• Other study ID #: LY2022-012-B
• Status: Not yet recruiting
• Start date: September 20, 2022
• Est. completion date: August 4, 2023

Study information

• Verified date: September 2022
• Source: RenJi Hospital
• Contact: Leilei WANG, master
• Phone: 8618801966298
• Email: wangleilei[@]renji.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The patients who underwent hip arthroplasty in our hospital from January 2017 to December 2020 were reviewed. The perioperative data were collected, and then the mortality was calculated and the risk factors were analyzed.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 900
• Est. completion date: August 4, 2023
• Est. primary completion date: August 4, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• All patients undergoing hip arthroplasty in Renji Hospital during 2017.1-2020.12

Exclusion Criteria:

• Patients who did not undergo surgery after admission Age < 18 years Patients undergoing the second operation

Related Conditions & MeSH terms

• Femoral Head Necrosis
• Femoral Neck Fractures
• Fracture of Neck of Femur (Hip)
• Hip Dislocation
• Necrosis

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
RenJi Hospital

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Risk factors of mortality one year after operation		From about even days before operation to 12 months after operation
Secondary	Risk factors of lower activities of daily living score at 12 months after operation		From about even days before operation to 12 months after operation